Showing results (1721-1730 of 3,615) with videos related to
Sort By:
Pageof 362
Journal of Viral Hepatitis|December 17, 2009
Chemerin, vaspin and insulin resistance in chronic hepatitis CM Kukla, K Zwirska-Korczala, A Gabriel, et al.Journal of Viral Hepatitis|April 17, 2018
Effectiveness and cost-effectiveness of interventions targeting harm reduction and chronic hepatitis C cascade of care in people who inject drugs: The case of FranceA Cousien, V C Tran, S Deuffic-Burban, et al.Journal of Viral Hepatitis|January 21, 2014
Uptake of hepatitis C treatment among people who inject drugs attending Needle and Syringe Programs in Australia, 1999-2011J Iversen, J Grebely, L Topp, et al.Journal of Viral Hepatitis|January 21, 2014
Canine hepacivirus is not associated with chronic liver disease in dogsN H Bexfield, P J Watson, J Heaney, et al.Journal of Viral Hepatitis|February 4, 2015
Definition of an HBsAg to DNA international unit conversion factor by enrichment of circulating hepatitis B virus formsN Désiré, Y Ngo, J-F Franetich, et al.Journal of Viral Hepatitis|March 12, 2015
Antiviral therapy in chronic hepatitis E: a systematic reviewA M Peters van Ton, T J G Gevers, J P H DrenthJournal of Viral Hepatitis|March 12, 2015
Experimental infection of pregnant rabbits with hepatitis E virus demonstrating high mortality and vertical transmissionJ Xia, L Liu, L Wang, et al.Journal of Viral Hepatitis|June 28, 2020
Beneficial effects of DAAs on cardiac function and structure in hepatitis C patients with low-moderate liver fibrosisAndrea Dalbeni, Simone Romano, Michele Bevilacqua, et al.Journal of Viral Hepatitis|January 22, 2015
Utility of the FIB-4 Index for hepatocarcinogenesis in hepatitis C virus carriers with normal alanine aminotransferase levelsT Ito, T Kumada, H Toyoda, et al.Journal of Viral Hepatitis|January 23, 2015
HCV genotype 3 and squamous cell carcinoma antigen (SCCA)-IgM are independently associated with histological features of NASH in HCV-infected patientsA Martini, G Fattovich, M Guido, et al.Pageof 362